Efficacy of clonidine versus phenobarbital in reducing neonatal morphine sulfate therapy days for neonatal abstinence syndrome. A prospective randomized clinical trial

Journal of Perinatology

Volumn 33, Issue 12, 2013, Pages 954-959

  Surran, B ^a,b   Visintainer, P ^c,d   Chamberlain, S ^a   Kopcza, K ^a   Shah, B ^a   Singh, R ^a  

^a Baystate Children's Hospital   (United States)

^b BOSTON MEDICAL CENTER   (United States)

^c BAYSTATE MEDICAL CENTER   (United States)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

buprenorphine; methadone; neurocognition; oxycodone; polydrug

Indexed keywords

CLONIDINE; MORPHINE SULFATE; PHENOBARBITAL;

ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; FEEDING DIFFICULTY; FEMALE; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; NEWBORN; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESPIRATION DEPRESSION; TREATMENT DURATION; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; CLONIDINE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INFANT, NEWBORN; MALE; MORPHINE; NEONATAL ABSTINENCE SYNDROME; PHENOBARBITAL; PROSPECTIVE STUDIES;

EID: 84888637113     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2013.95     Document Type: Article

References (35)

1. Khalsa J, Gfroerer J. Epidemiology and health consequences of drug abuse among pregnant women. Semin Perinatol 1991; 15: 265-270.
2. Dicker M, Leighton E. Trends in diagnosed drug problems among newborns:United States, 1979-1987. Drug Alcohol Depend 1991; 28: 151-165.
3. Finnegan L, Connaughton J, Kron R. A scoring system for evaluation and treatment of the neonatal abstinence syndrome: A new clinical and research tool. In:Marselli P, Garanttini S, Sereni F (eds). Basic and Therapeutic Aspects of Perinatal Pharmacology. Raven: New York, NY, USA, 1995, pp 139-152.
4. Patrick S, Schumacher R, Benneyworth B, Krans E, McAllister J, Davis M. Neonatal abstinence syndrome and associated health care expenditures United States, 2000-2009. JAMA 2012; 307: 1934-1940.
5. Doberczak T, Kandall S, Friedmann P. Relationships between maternal methadone dosage, maternal-neonatal methadone levels, and neonatal withdrawal. Obstet Gynecol 1993; 81: 936-940.
6. Mattick R, Breen C, Kimber J, Davoli M. Methadone maintenence therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev 2009; 3: CD002209.
7. Mack G, Thomas D, Giles W, Buchanan N. Methadone levels and neonatal withdrawal. J Paediatr Child Health 1991; 27: 96-100.
8. Jernite M, Vivelle B, Escande B, Brettes J, Messer J. Buprenorphine and pregnancy.Analysis of 24 cases. Arch Pediatr 1999; 6: 1179-1185.
9. Johnson R, Jones H, Jasinski D, Svikis DS, Haug NA, Jansson LM et al. Buprenorphine treatment of pregnant opioid-dependent women: Maternal and neonatal outcomes. Drug Alcohol Depend 2001; 63: 97-103.
10. Coyle M, Ferguson A, Lagasse L, Oh W, Lester B. Diluted tincture of opium (DTO) and Phenobarbital versus DTO alone for neonatal opiate withdrawal in term infants. J Pediatr 2002; 140: 561-564.
11. Agthe A, Kim G, Mathias K, Hendrix C, Chavez-Valdez R, Jansson L et al. Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: A randomized, controlled trial. Pediatrics 2009; 123: E849-e856.
12. Wachman E, Hayes M, Brown M, Paul J, Harvey-Wilkes K, Terrin N et al. Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome. JAMA 2013; 309: 1821-1827.
13. CDC Grand Rounds: Prescription Drug Overdoses - a U.S. Epidemic. CDC MMWR. January 2012; 61:10-13. Available at http://www.cdc.gov/mmwr/preview/ mmwrhtml/mm6101a3.htm. Accessed February 27 2013.
14. American Academy of Pediatrics Committee on Drugs and the Committee on Fetus and Newborn. Neonatal drug withdrawal. Pediatrics 2012; 129: E540-e560.
15. Sarkar S, Donn S. Management of neonatal abstinence syndrome in neonatal intensive care units: A national survey. J Perinatol 2006; 26: 15-17.
16. Chen J, Cai F, Cho J, Zhang X, Li S. Long-term antiepileptic drug administration during early life inhibits hippocampal neurogenesis in the developing brain. J Neurosci Res 2009; 87: 2898-2907.
17. Meador K, Baker G, Cohen M, Gaily E, Westerveld M. Cognitive/behavioral teratogenetic effects of antiepileptic drugs. Epilepsy Behav 2007; 11: 292-302.
18. Washton A, Resnick R. Clonidine in opiate withdrawal: Review and appraisal of clinical findings. Pharmacology 1981; 1: 140-146.
19. Kleber H, Gold M, Riordan C. The use of clonidine in detoxification from opiates. Bull Narc 1980; 32: 1-10.
20. Hoder E, Leckman J, Ehrenkranz R, Kleber H, Cohen D, Poulsen J. Clonidine in neonatal narcotic abstinence syndrome. N Engl J Med 1981; 305: 1284.
21. Leikin J, Mackendrick W, Maloney G, Rhee J, Farrell E, Wahl M et al. Use of clonidine in the prevention and management of neonatal abstinence syndrome. Clin Toxicol 2009; 47: 551-555.
22. Vittinghoff E, Glidden D, Shiboski S, McCulloch C. Regression Methods in Biostatistics: Linear, Logistic, Survival, and Repeated Measures Models. 2nd edn. Springer: New York, NY, USA, 2012.
23. Proschan M, Lan K, Wittes J. Statistical Monitoring of Clinical Trials: A Unified Approach. Springer: New York, NY, USA, 2010.
24. Chen Y, DeMets D, Lan K. Increasing the sample size when the unblinded interim result is promising. Stat Med 2004; 23: 1023-1038.
25. Liu A, Bjorkman T, Stewart C, Nanan R. Pharmacological treatment of neonatal opiate withdrawal: Between the devil and the deep blue sea. Int J Pediatr 2011; 2011: 935631.
26. Ebner N, Rohrmeister K, Winklbaur B. Management of neonatal abstinence syndrome in neonates born to opioid maintained women. Drug Alcohol Depend 2007; 87: 131.
27. Coyle M, Ferguson A, LaGasse L, Liu J, Lester B. Neurobehavioral effects of treatment for opiate withdrawal. Arch Dis Child Fetal Neonatal Ed 2005; 90: F73-F74.
28. Forcelli P, Janssen M, Stamps L, Sweeney C, Vicini S, Gale K. Therapeutic strategies to avoid long-term adverse outcomes of neonatal antiepileptic drug exposure. Epilepsia 2010; 51: 18-23.
29. Chen J, Cai F, Cao J, Zhang X, Li S. Long-term antiepileptic drug administration during early life inhibits hippocampal neurogenesis in the developing brain. J Neurosci Res 2009; 87: 2898-2907.
30. Stefovska V, Uckermann O, Czuczwar M, Smitka M, Czuczwar P, Kis J et al. Sedative and anticonvulsant drugs suppress postnatal neurogenesis. Ann Neurol 2008; 64:434-445.
31. Reinisch J, Sanders S, Mortensen E, Rubin D. In utero exposure to phenobarbital and intelligence deficits in adult men. JAMA 1995; 274: 1518-1525.
32. Bhardwaj S, Forcelli P, Palchik G, Gale K, Srivastava L, Kondratyev A. Neonatal exposure to phenobarbital potentiates schizophrenia-like behavioral outcomes in the rat. Neuropharmacology 2012; 62: 2336-2344.
33. American Academy of Pediatrics Committee on Drugs. Ethanol in liquid preparations intended for children. Pediatrics 1984; 73: 405.
34. Levinson M, Johnson C. Stability of an extemporaneously compounded clonidine hydrochloride oral liquid. Am J Hosp Pharm 1992; 49: 122-125.
35. Xie H, Cao Y, Gauda E, Agthe A, Hendrix C, Lee H. Clonidine clearance matures rapidly during the early postnatal period: A population pharmacokinetic analysis in newborns with neonatal abstinence syndrome. J Clin Pharmacol 2011; 51: 502-511.